Glofitamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2229047-91-8
Synonyms
RG6026, RO7082859
SKU
C00881-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Glofitamab is a T-cell–engaging bispecific antibody that targets CD3 and CD20, demonstrating significant antitumor activity and durable responses in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) . It works by binding to CD20 on B cells and CD3 on T cells, promoting T-cell-mediated lysis of malignant B cells. MW: 170.28 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
138367 100 µg
SLC2A8, Control Peptide (Solute Carrier Family 2, Facilitated Glucose Transporter Member 8, Glucose Transporter Type 8, GLUT-8, Glucose Transporter Type X1, GLUT8, GLUTX1)
Sign In for Pricing
View Details W1450-51A 50 µg
WISP1 (Wnt1-inducible-signaling Pathway Protein 1, WISP-1, CCN Family Member 4, Wnt-1-induced Secreted Protein, CCN4) discontinued
Sign In for Pricing
View Details